nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—pancreatitis—pancreatic cancer	0.867	1	CtDrD
Hyoscyamine—Confusional state—Fluorouracil—pancreatic cancer	0.000104	0.00109	CcSEcCtD
Hyoscyamine—Abdominal pain—Sunitinib—pancreatic cancer	0.000103	0.00108	CcSEcCtD
Hyoscyamine—Body temperature increased—Sunitinib—pancreatic cancer	0.000103	0.00108	CcSEcCtD
Hyoscyamine—Diarrhoea—Erlotinib—pancreatic cancer	0.000103	0.00108	CcSEcCtD
Hyoscyamine—Oedema—Fluorouracil—pancreatic cancer	0.000103	0.00108	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000103	0.00108	CcSEcCtD
Hyoscyamine—Hyponatraemia—Epirubicin—pancreatic cancer	0.000103	0.00107	CcSEcCtD
Hyoscyamine—Osteoarthritis—Epirubicin—pancreatic cancer	0.000102	0.00107	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000101	0.00106	CcSEcCtD
Hyoscyamine—Dizziness—Tamoxifen—pancreatic cancer	0.000101	0.00106	CcSEcCtD
Hyoscyamine—Tachycardia—Fluorouracil—pancreatic cancer	0.000101	0.00105	CcSEcCtD
Hyoscyamine—Hypotension—Irinotecan—pancreatic cancer	0.000101	0.00105	CcSEcCtD
Hyoscyamine—Dizziness—Erlotinib—pancreatic cancer	9.99e-05	0.00105	CcSEcCtD
Hyoscyamine—Hypotension—Gemcitabine—pancreatic cancer	9.8e-05	0.00103	CcSEcCtD
Hyoscyamine—Insomnia—Irinotecan—pancreatic cancer	9.74e-05	0.00102	CcSEcCtD
Hyoscyamine—Flushing—Docetaxel—pancreatic cancer	9.73e-05	0.00102	CcSEcCtD
Hyoscyamine—Cardiac arrest—Epirubicin—pancreatic cancer	9.72e-05	0.00102	CcSEcCtD
Hyoscyamine—Vomiting—Tamoxifen—pancreatic cancer	9.71e-05	0.00102	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Doxorubicin—pancreatic cancer	9.69e-05	0.00101	CcSEcCtD
Hyoscyamine—Lethargy—Doxorubicin—pancreatic cancer	9.65e-05	0.00101	CcSEcCtD
Hyoscyamine—Hypotension—Fluorouracil—pancreatic cancer	9.64e-05	0.00101	CcSEcCtD
Hyoscyamine—Hypersensitivity—Sunitinib—pancreatic cancer	9.63e-05	0.00101	CcSEcCtD
Hyoscyamine—Rash—Tamoxifen—pancreatic cancer	9.63e-05	0.00101	CcSEcCtD
Hyoscyamine—Dermatitis—Tamoxifen—pancreatic cancer	9.62e-05	0.00101	CcSEcCtD
Hyoscyamine—Ataxia—Epirubicin—pancreatic cancer	9.61e-05	0.00101	CcSEcCtD
Hyoscyamine—Vomiting—Erlotinib—pancreatic cancer	9.6e-05	0.00101	CcSEcCtD
Hyoscyamine—Dyspnoea—Irinotecan—pancreatic cancer	9.6e-05	0.00101	CcSEcCtD
Hyoscyamine—Somnolence—Irinotecan—pancreatic cancer	9.58e-05	0.001	CcSEcCtD
Hyoscyamine—Headache—Tamoxifen—pancreatic cancer	9.56e-05	0.001	CcSEcCtD
Hyoscyamine—Rash—Erlotinib—pancreatic cancer	9.52e-05	0.000998	CcSEcCtD
Hyoscyamine—Dermatitis—Erlotinib—pancreatic cancer	9.52e-05	0.000997	CcSEcCtD
Hyoscyamine—Dehydration—Epirubicin—pancreatic cancer	9.5e-05	0.000996	CcSEcCtD
Hyoscyamine—Hyponatraemia—Doxorubicin—pancreatic cancer	9.49e-05	0.000994	CcSEcCtD
Hyoscyamine—Insomnia—Gemcitabine—pancreatic cancer	9.49e-05	0.000994	CcSEcCtD
Hyoscyamine—Dyspepsia—Irinotecan—pancreatic cancer	9.48e-05	0.000993	CcSEcCtD
Hyoscyamine—Headache—Erlotinib—pancreatic cancer	9.46e-05	0.000991	CcSEcCtD
Hyoscyamine—Osteoarthritis—Doxorubicin—pancreatic cancer	9.45e-05	0.00099	CcSEcCtD
Hyoscyamine—Asthenia—Sunitinib—pancreatic cancer	9.38e-05	0.000983	CcSEcCtD
Hyoscyamine—Dry skin—Epirubicin—pancreatic cancer	9.37e-05	0.000981	CcSEcCtD
Hyoscyamine—Arrhythmia—Docetaxel—pancreatic cancer	9.36e-05	0.000981	CcSEcCtD
Hyoscyamine—Dyspnoea—Gemcitabine—pancreatic cancer	9.35e-05	0.00098	CcSEcCtD
Hyoscyamine—Insomnia—Fluorouracil—pancreatic cancer	9.33e-05	0.000977	CcSEcCtD
Hyoscyamine—Somnolence—Gemcitabine—pancreatic cancer	9.33e-05	0.000977	CcSEcCtD
Hyoscyamine—Hypokalaemia—Epirubicin—pancreatic cancer	9.3e-05	0.000974	CcSEcCtD
Hyoscyamine—Fatigue—Irinotecan—pancreatic cancer	9.29e-05	0.000973	CcSEcCtD
Hyoscyamine—Pruritus—Sunitinib—pancreatic cancer	9.25e-05	0.000969	CcSEcCtD
Hyoscyamine—Pain—Irinotecan—pancreatic cancer	9.21e-05	0.000965	CcSEcCtD
Hyoscyamine—Constipation—Irinotecan—pancreatic cancer	9.21e-05	0.000965	CcSEcCtD
Hyoscyamine—Dyspnoea—Fluorouracil—pancreatic cancer	9.2e-05	0.000964	CcSEcCtD
Hyoscyamine—Mental disorder—Docetaxel—pancreatic cancer	9.18e-05	0.000962	CcSEcCtD
Hyoscyamine—Somnolence—Fluorouracil—pancreatic cancer	9.17e-05	0.000961	CcSEcCtD
Hyoscyamine—Erythema—Docetaxel—pancreatic cancer	9.12e-05	0.000956	CcSEcCtD
Hyoscyamine—Dyspepsia—Fluorouracil—pancreatic cancer	9.08e-05	0.000951	CcSEcCtD
Hyoscyamine—Nausea—Tamoxifen—pancreatic cancer	9.07e-05	0.00095	CcSEcCtD
Hyoscyamine—Fatigue—Gemcitabine—pancreatic cancer	9.05e-05	0.000948	CcSEcCtD
Hyoscyamine—Cardiac arrest—Doxorubicin—pancreatic cancer	8.99e-05	0.000942	CcSEcCtD
Hyoscyamine—Constipation—Gemcitabine—pancreatic cancer	8.97e-05	0.00094	CcSEcCtD
Hyoscyamine—Pain—Gemcitabine—pancreatic cancer	8.97e-05	0.00094	CcSEcCtD
Hyoscyamine—Nausea—Erlotinib—pancreatic cancer	8.97e-05	0.00094	CcSEcCtD
Hyoscyamine—Diarrhoea—Sunitinib—pancreatic cancer	8.95e-05	0.000937	CcSEcCtD
Hyoscyamine—Dysgeusia—Docetaxel—pancreatic cancer	8.93e-05	0.000936	CcSEcCtD
Hyoscyamine—Abdominal distension—Epirubicin—pancreatic cancer	8.89e-05	0.000931	CcSEcCtD
Hyoscyamine—Ataxia—Doxorubicin—pancreatic cancer	8.89e-05	0.000931	CcSEcCtD
Hyoscyamine—Feeling abnormal—Irinotecan—pancreatic cancer	8.88e-05	0.00093	CcSEcCtD
Hyoscyamine—Dysphagia—Epirubicin—pancreatic cancer	8.83e-05	0.000925	CcSEcCtD
Hyoscyamine—Pain—Fluorouracil—pancreatic cancer	8.82e-05	0.000924	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Irinotecan—pancreatic cancer	8.81e-05	0.000923	CcSEcCtD
Hyoscyamine—Dehydration—Doxorubicin—pancreatic cancer	8.79e-05	0.000921	CcSEcCtD
Hyoscyamine—Dry skin—Doxorubicin—pancreatic cancer	8.67e-05	0.000908	CcSEcCtD
Hyoscyamine—Dizziness—Sunitinib—pancreatic cancer	8.65e-05	0.000906	CcSEcCtD
Hyoscyamine—Feeling abnormal—Gemcitabine—pancreatic cancer	8.65e-05	0.000906	CcSEcCtD
Hyoscyamine—Hypokalaemia—Doxorubicin—pancreatic cancer	8.6e-05	0.000901	CcSEcCtD
Hyoscyamine—Angina pectoris—Epirubicin—pancreatic cancer	8.6e-05	0.000901	CcSEcCtD
Hyoscyamine—Body temperature increased—Irinotecan—pancreatic cancer	8.51e-05	0.000892	CcSEcCtD
Hyoscyamine—Abdominal pain—Irinotecan—pancreatic cancer	8.51e-05	0.000892	CcSEcCtD
Hyoscyamine—Feeling abnormal—Fluorouracil—pancreatic cancer	8.5e-05	0.000891	CcSEcCtD
Hyoscyamine—Vomiting—Sunitinib—pancreatic cancer	8.31e-05	0.000871	CcSEcCtD
Hyoscyamine—Body temperature increased—Gemcitabine—pancreatic cancer	8.29e-05	0.000869	CcSEcCtD
Hyoscyamine—Dysuria—Epirubicin—pancreatic cancer	8.26e-05	0.000865	CcSEcCtD
Hyoscyamine—Rash—Sunitinib—pancreatic cancer	8.24e-05	0.000864	CcSEcCtD
Hyoscyamine—Dermatitis—Sunitinib—pancreatic cancer	8.24e-05	0.000863	CcSEcCtD
Hyoscyamine—Abdominal distension—Doxorubicin—pancreatic cancer	8.23e-05	0.000862	CcSEcCtD
Hyoscyamine—Urticaria—Fluorouracil—pancreatic cancer	8.2e-05	0.000859	CcSEcCtD
Hyoscyamine—Headache—Sunitinib—pancreatic cancer	8.19e-05	0.000858	CcSEcCtD
Hyoscyamine—Syncope—Docetaxel—pancreatic cancer	8.18e-05	0.000857	CcSEcCtD
Hyoscyamine—Dysphagia—Doxorubicin—pancreatic cancer	8.17e-05	0.000856	CcSEcCtD
Hyoscyamine—Body temperature increased—Fluorouracil—pancreatic cancer	8.15e-05	0.000854	CcSEcCtD
Hyoscyamine—Palpitations—Docetaxel—pancreatic cancer	8.06e-05	0.000845	CcSEcCtD
Hyoscyamine—Loss of consciousness—Docetaxel—pancreatic cancer	8.02e-05	0.00084	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Epirubicin—pancreatic cancer	7.97e-05	0.000835	CcSEcCtD
Hyoscyamine—Angina pectoris—Doxorubicin—pancreatic cancer	7.96e-05	0.000834	CcSEcCtD
Hyoscyamine—Hypersensitivity—Irinotecan—pancreatic cancer	7.94e-05	0.000831	CcSEcCtD
Hyoscyamine—Convulsion—Docetaxel—pancreatic cancer	7.9e-05	0.000828	CcSEcCtD
Hyoscyamine—Drowsiness—Epirubicin—pancreatic cancer	7.87e-05	0.000825	CcSEcCtD
Hyoscyamine—Chest pain—Docetaxel—pancreatic cancer	7.77e-05	0.000814	CcSEcCtD
Hyoscyamine—Nausea—Sunitinib—pancreatic cancer	7.77e-05	0.000814	CcSEcCtD
Hyoscyamine—Asthenia—Irinotecan—pancreatic cancer	7.73e-05	0.00081	CcSEcCtD
Hyoscyamine—Conjunctivitis—Epirubicin—pancreatic cancer	7.65e-05	0.000802	CcSEcCtD
Hyoscyamine—Dysuria—Doxorubicin—pancreatic cancer	7.64e-05	0.000801	CcSEcCtD
Hyoscyamine—Hypersensitivity—Fluorouracil—pancreatic cancer	7.6e-05	0.000796	CcSEcCtD
Hyoscyamine—Dry mouth—Docetaxel—pancreatic cancer	7.6e-05	0.000796	CcSEcCtD
Hyoscyamine—Sweating—Epirubicin—pancreatic cancer	7.55e-05	0.000791	CcSEcCtD
Hyoscyamine—Asthenia—Gemcitabine—pancreatic cancer	7.53e-05	0.000789	CcSEcCtD
Hyoscyamine—Confusional state—Docetaxel—pancreatic cancer	7.51e-05	0.000787	CcSEcCtD
Hyoscyamine—Oedema—Docetaxel—pancreatic cancer	7.45e-05	0.00078	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Docetaxel—pancreatic cancer	7.45e-05	0.00078	CcSEcCtD
Hyoscyamine—Pruritus—Gemcitabine—pancreatic cancer	7.42e-05	0.000778	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Doxorubicin—pancreatic cancer	7.37e-05	0.000772	CcSEcCtD
Hyoscyamine—Diarrhoea—Irinotecan—pancreatic cancer	7.37e-05	0.000772	CcSEcCtD
Hyoscyamine—Shock—Docetaxel—pancreatic cancer	7.33e-05	0.000767	CcSEcCtD
Hyoscyamine—Pruritus—Fluorouracil—pancreatic cancer	7.3e-05	0.000765	CcSEcCtD
Hyoscyamine—Drowsiness—Doxorubicin—pancreatic cancer	7.29e-05	0.000763	CcSEcCtD
Hyoscyamine—Tachycardia—Docetaxel—pancreatic cancer	7.27e-05	0.000761	CcSEcCtD
Hyoscyamine—Bradycardia—Epirubicin—pancreatic cancer	7.2e-05	0.000754	CcSEcCtD
Hyoscyamine—Diarrhoea—Gemcitabine—pancreatic cancer	7.18e-05	0.000752	CcSEcCtD
Hyoscyamine—Dizziness—Irinotecan—pancreatic cancer	7.12e-05	0.000746	CcSEcCtD
Hyoscyamine—Conjunctivitis—Doxorubicin—pancreatic cancer	7.08e-05	0.000742	CcSEcCtD
Hyoscyamine—Diarrhoea—Fluorouracil—pancreatic cancer	7.06e-05	0.000739	CcSEcCtD
Hyoscyamine—Sweating—Doxorubicin—pancreatic cancer	6.98e-05	0.000732	CcSEcCtD
Hyoscyamine—Hypotension—Docetaxel—pancreatic cancer	6.96e-05	0.000729	CcSEcCtD
Hyoscyamine—Vomiting—Irinotecan—pancreatic cancer	6.85e-05	0.000717	CcSEcCtD
Hyoscyamine—Dizziness—Fluorouracil—pancreatic cancer	6.82e-05	0.000715	CcSEcCtD
Hyoscyamine—Rash—Irinotecan—pancreatic cancer	6.79e-05	0.000711	CcSEcCtD
Hyoscyamine—Dermatitis—Irinotecan—pancreatic cancer	6.79e-05	0.000711	CcSEcCtD
Hyoscyamine—Headache—Irinotecan—pancreatic cancer	6.75e-05	0.000707	CcSEcCtD
Hyoscyamine—Insomnia—Docetaxel—pancreatic cancer	6.73e-05	0.000706	CcSEcCtD
Hyoscyamine—Vomiting—Gemcitabine—pancreatic cancer	6.67e-05	0.000699	CcSEcCtD
Hyoscyamine—Bradycardia—Doxorubicin—pancreatic cancer	6.66e-05	0.000698	CcSEcCtD
Hyoscyamine—Dyspnoea—Docetaxel—pancreatic cancer	6.64e-05	0.000695	CcSEcCtD
Hyoscyamine—Somnolence—Docetaxel—pancreatic cancer	6.62e-05	0.000693	CcSEcCtD
Hyoscyamine—Rash—Gemcitabine—pancreatic cancer	6.62e-05	0.000693	CcSEcCtD
Hyoscyamine—Dermatitis—Gemcitabine—pancreatic cancer	6.61e-05	0.000692	CcSEcCtD
Hyoscyamine—Headache—Gemcitabine—pancreatic cancer	6.57e-05	0.000689	CcSEcCtD
Hyoscyamine—Flushing—Epirubicin—pancreatic cancer	6.56e-05	0.000687	CcSEcCtD
Hyoscyamine—Vomiting—Fluorouracil—pancreatic cancer	6.56e-05	0.000687	CcSEcCtD
Hyoscyamine—Dyspepsia—Docetaxel—pancreatic cancer	6.55e-05	0.000687	CcSEcCtD
Hyoscyamine—Rash—Fluorouracil—pancreatic cancer	6.5e-05	0.000681	CcSEcCtD
Hyoscyamine—Dermatitis—Fluorouracil—pancreatic cancer	6.5e-05	0.000681	CcSEcCtD
Hyoscyamine—Headache—Fluorouracil—pancreatic cancer	6.46e-05	0.000677	CcSEcCtD
Hyoscyamine—Fatigue—Docetaxel—pancreatic cancer	6.42e-05	0.000673	CcSEcCtD
Hyoscyamine—Nausea—Irinotecan—pancreatic cancer	6.4e-05	0.00067	CcSEcCtD
Hyoscyamine—Pain—Docetaxel—pancreatic cancer	6.37e-05	0.000667	CcSEcCtD
Hyoscyamine—Constipation—Docetaxel—pancreatic cancer	6.37e-05	0.000667	CcSEcCtD
Hyoscyamine—Arrhythmia—Epirubicin—pancreatic cancer	6.31e-05	0.000662	CcSEcCtD
Hyoscyamine—Nausea—Gemcitabine—pancreatic cancer	6.23e-05	0.000653	CcSEcCtD
Hyoscyamine—Mental disorder—Epirubicin—pancreatic cancer	6.19e-05	0.000649	CcSEcCtD
Hyoscyamine—Erythema—Epirubicin—pancreatic cancer	6.15e-05	0.000645	CcSEcCtD
Hyoscyamine—Feeling abnormal—Docetaxel—pancreatic cancer	6.14e-05	0.000643	CcSEcCtD
Hyoscyamine—Nausea—Fluorouracil—pancreatic cancer	6.13e-05	0.000642	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.09e-05	0.000638	CcSEcCtD
Hyoscyamine—Flushing—Doxorubicin—pancreatic cancer	6.07e-05	0.000636	CcSEcCtD
Hyoscyamine—Tension—Epirubicin—pancreatic cancer	6.04e-05	0.000633	CcSEcCtD
Hyoscyamine—Dysgeusia—Epirubicin—pancreatic cancer	6.03e-05	0.000631	CcSEcCtD
Hyoscyamine—Nervousness—Epirubicin—pancreatic cancer	5.98e-05	0.000626	CcSEcCtD
Hyoscyamine—Body temperature increased—Docetaxel—pancreatic cancer	5.89e-05	0.000617	CcSEcCtD
Hyoscyamine—Abdominal pain—Docetaxel—pancreatic cancer	5.89e-05	0.000617	CcSEcCtD
Hyoscyamine—Arrhythmia—Doxorubicin—pancreatic cancer	5.84e-05	0.000612	CcSEcCtD
Hyoscyamine—Vision blurred—Epirubicin—pancreatic cancer	5.8e-05	0.000608	CcSEcCtD
Hyoscyamine—Mental disorder—Doxorubicin—pancreatic cancer	5.73e-05	0.0006	CcSEcCtD
Hyoscyamine—Erythema—Doxorubicin—pancreatic cancer	5.69e-05	0.000596	CcSEcCtD
Hyoscyamine—Agitation—Epirubicin—pancreatic cancer	5.65e-05	0.000592	CcSEcCtD
Hyoscyamine—Tension—Doxorubicin—pancreatic cancer	5.59e-05	0.000585	CcSEcCtD
Hyoscyamine—Dysgeusia—Doxorubicin—pancreatic cancer	5.58e-05	0.000584	CcSEcCtD
Hyoscyamine—Nervousness—Doxorubicin—pancreatic cancer	5.53e-05	0.000579	CcSEcCtD
Hyoscyamine—Vertigo—Epirubicin—pancreatic cancer	5.53e-05	0.000579	CcSEcCtD
Hyoscyamine—Syncope—Epirubicin—pancreatic cancer	5.52e-05	0.000578	CcSEcCtD
Hyoscyamine—Hypersensitivity—Docetaxel—pancreatic cancer	5.49e-05	0.000575	CcSEcCtD
Hyoscyamine—Palpitations—Epirubicin—pancreatic cancer	5.44e-05	0.00057	CcSEcCtD
Hyoscyamine—Loss of consciousness—Epirubicin—pancreatic cancer	5.41e-05	0.000567	CcSEcCtD
Hyoscyamine—Vision blurred—Doxorubicin—pancreatic cancer	5.37e-05	0.000562	CcSEcCtD
Hyoscyamine—Asthenia—Docetaxel—pancreatic cancer	5.34e-05	0.00056	CcSEcCtD
Hyoscyamine—Convulsion—Epirubicin—pancreatic cancer	5.33e-05	0.000559	CcSEcCtD
Hyoscyamine—Pruritus—Docetaxel—pancreatic cancer	5.27e-05	0.000552	CcSEcCtD
Hyoscyamine—Chest pain—Epirubicin—pancreatic cancer	5.24e-05	0.000549	CcSEcCtD
Hyoscyamine—Agitation—Doxorubicin—pancreatic cancer	5.23e-05	0.000548	CcSEcCtD
Hyoscyamine—Anxiety—Epirubicin—pancreatic cancer	5.22e-05	0.000547	CcSEcCtD
Hyoscyamine—Dry mouth—Epirubicin—pancreatic cancer	5.12e-05	0.000537	CcSEcCtD
Hyoscyamine—Vertigo—Doxorubicin—pancreatic cancer	5.12e-05	0.000536	CcSEcCtD
Hyoscyamine—Syncope—Doxorubicin—pancreatic cancer	5.11e-05	0.000535	CcSEcCtD
Hyoscyamine—Diarrhoea—Docetaxel—pancreatic cancer	5.09e-05	0.000534	CcSEcCtD
Hyoscyamine—Confusional state—Epirubicin—pancreatic cancer	5.06e-05	0.000531	CcSEcCtD
Hyoscyamine—Palpitations—Doxorubicin—pancreatic cancer	5.03e-05	0.000527	CcSEcCtD
Hyoscyamine—Oedema—Epirubicin—pancreatic cancer	5.02e-05	0.000526	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Epirubicin—pancreatic cancer	5.02e-05	0.000526	CcSEcCtD
Hyoscyamine—Loss of consciousness—Doxorubicin—pancreatic cancer	5e-05	0.000524	CcSEcCtD
Hyoscyamine—Shock—Epirubicin—pancreatic cancer	4.94e-05	0.000518	CcSEcCtD
Hyoscyamine—Convulsion—Doxorubicin—pancreatic cancer	4.93e-05	0.000517	CcSEcCtD
Hyoscyamine—Dizziness—Docetaxel—pancreatic cancer	4.92e-05	0.000516	CcSEcCtD
Hyoscyamine—Tachycardia—Epirubicin—pancreatic cancer	4.9e-05	0.000513	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Epirubicin—pancreatic cancer	4.86e-05	0.000509	CcSEcCtD
Hyoscyamine—Chest pain—Doxorubicin—pancreatic cancer	4.85e-05	0.000508	CcSEcCtD
Hyoscyamine—Anxiety—Doxorubicin—pancreatic cancer	4.83e-05	0.000506	CcSEcCtD
Hyoscyamine—Dry mouth—Doxorubicin—pancreatic cancer	4.74e-05	0.000497	CcSEcCtD
Hyoscyamine—Vomiting—Docetaxel—pancreatic cancer	4.73e-05	0.000496	CcSEcCtD
Hyoscyamine—Rash—Docetaxel—pancreatic cancer	4.69e-05	0.000492	CcSEcCtD
Hyoscyamine—Hypotension—Epirubicin—pancreatic cancer	4.69e-05	0.000492	CcSEcCtD
Hyoscyamine—Dermatitis—Docetaxel—pancreatic cancer	4.69e-05	0.000491	CcSEcCtD
Hyoscyamine—Confusional state—Doxorubicin—pancreatic cancer	4.69e-05	0.000491	CcSEcCtD
Hyoscyamine—Headache—Docetaxel—pancreatic cancer	4.66e-05	0.000489	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Doxorubicin—pancreatic cancer	4.65e-05	0.000487	CcSEcCtD
Hyoscyamine—Oedema—Doxorubicin—pancreatic cancer	4.65e-05	0.000487	CcSEcCtD
Hyoscyamine—Shock—Doxorubicin—pancreatic cancer	4.57e-05	0.000479	CcSEcCtD
Hyoscyamine—Insomnia—Epirubicin—pancreatic cancer	4.54e-05	0.000476	CcSEcCtD
Hyoscyamine—Tachycardia—Doxorubicin—pancreatic cancer	4.54e-05	0.000475	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.49e-05	0.000471	CcSEcCtD
Hyoscyamine—Dyspnoea—Epirubicin—pancreatic cancer	4.48e-05	0.000469	CcSEcCtD
Hyoscyamine—Somnolence—Epirubicin—pancreatic cancer	4.46e-05	0.000468	CcSEcCtD
Hyoscyamine—Nausea—Docetaxel—pancreatic cancer	4.42e-05	0.000463	CcSEcCtD
Hyoscyamine—Dyspepsia—Epirubicin—pancreatic cancer	4.42e-05	0.000463	CcSEcCtD
Hyoscyamine—Hypotension—Doxorubicin—pancreatic cancer	4.34e-05	0.000455	CcSEcCtD
Hyoscyamine—Fatigue—Epirubicin—pancreatic cancer	4.33e-05	0.000454	CcSEcCtD
Hyoscyamine—Pain—Epirubicin—pancreatic cancer	4.29e-05	0.00045	CcSEcCtD
Hyoscyamine—Constipation—Epirubicin—pancreatic cancer	4.29e-05	0.00045	CcSEcCtD
Hyoscyamine—Insomnia—Doxorubicin—pancreatic cancer	4.2e-05	0.00044	CcSEcCtD
Hyoscyamine—Dyspnoea—Doxorubicin—pancreatic cancer	4.14e-05	0.000434	CcSEcCtD
Hyoscyamine—Feeling abnormal—Epirubicin—pancreatic cancer	4.14e-05	0.000434	CcSEcCtD
Hyoscyamine—Somnolence—Doxorubicin—pancreatic cancer	4.13e-05	0.000433	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.11e-05	0.00043	CcSEcCtD
Hyoscyamine—Dyspepsia—Doxorubicin—pancreatic cancer	4.09e-05	0.000429	CcSEcCtD
Hyoscyamine—Fatigue—Doxorubicin—pancreatic cancer	4.01e-05	0.00042	CcSEcCtD
Hyoscyamine—Urticaria—Epirubicin—pancreatic cancer	3.99e-05	0.000418	CcSEcCtD
Hyoscyamine—Pain—Doxorubicin—pancreatic cancer	3.97e-05	0.000416	CcSEcCtD
Hyoscyamine—Constipation—Doxorubicin—pancreatic cancer	3.97e-05	0.000416	CcSEcCtD
Hyoscyamine—Abdominal pain—Epirubicin—pancreatic cancer	3.97e-05	0.000416	CcSEcCtD
Hyoscyamine—Body temperature increased—Epirubicin—pancreatic cancer	3.97e-05	0.000416	CcSEcCtD
Hyoscyamine—Feeling abnormal—Doxorubicin—pancreatic cancer	3.83e-05	0.000401	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.8e-05	0.000398	CcSEcCtD
Hyoscyamine—Hypersensitivity—Epirubicin—pancreatic cancer	3.7e-05	0.000388	CcSEcCtD
Hyoscyamine—Urticaria—Doxorubicin—pancreatic cancer	3.69e-05	0.000387	CcSEcCtD
Hyoscyamine—Body temperature increased—Doxorubicin—pancreatic cancer	3.67e-05	0.000385	CcSEcCtD
Hyoscyamine—Abdominal pain—Doxorubicin—pancreatic cancer	3.67e-05	0.000385	CcSEcCtD
Hyoscyamine—Asthenia—Epirubicin—pancreatic cancer	3.6e-05	0.000377	CcSEcCtD
Hyoscyamine—Pruritus—Epirubicin—pancreatic cancer	3.55e-05	0.000372	CcSEcCtD
Hyoscyamine—Diarrhoea—Epirubicin—pancreatic cancer	3.44e-05	0.00036	CcSEcCtD
Hyoscyamine—Hypersensitivity—Doxorubicin—pancreatic cancer	3.42e-05	0.000359	CcSEcCtD
Hyoscyamine—Asthenia—Doxorubicin—pancreatic cancer	3.33e-05	0.000349	CcSEcCtD
Hyoscyamine—Dizziness—Epirubicin—pancreatic cancer	3.32e-05	0.000348	CcSEcCtD
Hyoscyamine—Pruritus—Doxorubicin—pancreatic cancer	3.29e-05	0.000344	CcSEcCtD
Hyoscyamine—Vomiting—Epirubicin—pancreatic cancer	3.19e-05	0.000335	CcSEcCtD
Hyoscyamine—Diarrhoea—Doxorubicin—pancreatic cancer	3.18e-05	0.000333	CcSEcCtD
Hyoscyamine—Rash—Epirubicin—pancreatic cancer	3.17e-05	0.000332	CcSEcCtD
Hyoscyamine—Dermatitis—Epirubicin—pancreatic cancer	3.16e-05	0.000331	CcSEcCtD
Hyoscyamine—Headache—Epirubicin—pancreatic cancer	3.15e-05	0.00033	CcSEcCtD
Hyoscyamine—Dizziness—Doxorubicin—pancreatic cancer	3.07e-05	0.000322	CcSEcCtD
Hyoscyamine—Nausea—Epirubicin—pancreatic cancer	2.98e-05	0.000313	CcSEcCtD
Hyoscyamine—Vomiting—Doxorubicin—pancreatic cancer	2.95e-05	0.00031	CcSEcCtD
Hyoscyamine—Rash—Doxorubicin—pancreatic cancer	2.93e-05	0.000307	CcSEcCtD
Hyoscyamine—Dermatitis—Doxorubicin—pancreatic cancer	2.93e-05	0.000307	CcSEcCtD
Hyoscyamine—Headache—Doxorubicin—pancreatic cancer	2.91e-05	0.000305	CcSEcCtD
Hyoscyamine—Nausea—Doxorubicin—pancreatic cancer	2.76e-05	0.000289	CcSEcCtD
Hyoscyamine—CHRM3—Signaling Pathways—GLP1R—pancreatic cancer	1.55e-05	0.000414	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CXCL8—pancreatic cancer	1.55e-05	0.000414	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	1.53e-05	0.00041	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	1.53e-05	0.00041	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	1.53e-05	0.00041	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCKAR—pancreatic cancer	1.53e-05	0.000409	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AGTR1—pancreatic cancer	1.52e-05	0.000408	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCKAR—pancreatic cancer	1.52e-05	0.000408	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	1.51e-05	0.000404	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—STK11—pancreatic cancer	1.5e-05	0.000402	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—JAG2—pancreatic cancer	1.48e-05	0.000397	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—JAG2—pancreatic cancer	1.48e-05	0.000395	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	1.46e-05	0.000391	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MEN1—pancreatic cancer	1.46e-05	0.000391	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MEN1—pancreatic cancer	1.46e-05	0.00039	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	1.44e-05	0.000386	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—PIK3CD—pancreatic cancer	1.41e-05	0.000377	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SHH—pancreatic cancer	1.39e-05	0.000373	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SHH—pancreatic cancer	1.39e-05	0.000372	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOTCH4—pancreatic cancer	1.38e-05	0.000371	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOTCH4—pancreatic cancer	1.38e-05	0.000369	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IAPP—pancreatic cancer	1.38e-05	0.000368	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SHH—pancreatic cancer	1.38e-05	0.000368	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IAPP—pancreatic cancer	1.37e-05	0.000367	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	1.37e-05	0.000366	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	1.36e-05	0.000363	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.35e-05	0.000362	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CD44—pancreatic cancer	1.34e-05	0.000358	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTHLH—pancreatic cancer	1.32e-05	0.000353	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTCH1—pancreatic cancer	1.32e-05	0.000353	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTHLH—pancreatic cancer	1.32e-05	0.000352	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTCH1—pancreatic cancer	1.32e-05	0.000352	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SMAD4—pancreatic cancer	1.31e-05	0.000352	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	1.3e-05	0.000349	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	1.3e-05	0.000349	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CXCL8—pancreatic cancer	1.3e-05	0.000348	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HES1—pancreatic cancer	1.28e-05	0.000344	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GCG—pancreatic cancer	1.28e-05	0.000343	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—PIK3CB—pancreatic cancer	1.23e-05	0.000329	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SST—pancreatic cancer	1.21e-05	0.000323	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—STK11—pancreatic cancer	1.21e-05	0.000323	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SST—pancreatic cancer	1.2e-05	0.000322	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SST—pancreatic cancer	1.19e-05	0.000319	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.19e-05	0.000319	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.19e-05	0.000318	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—JAG1—pancreatic cancer	1.18e-05	0.000316	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CXCL8—pancreatic cancer	1.18e-05	0.000316	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	1.18e-05	0.000315	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOTCH3—pancreatic cancer	1.18e-05	0.000315	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.18e-05	0.000315	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	1.17e-05	0.000314	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	1.17e-05	0.000312	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	1.16e-05	0.000311	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TERT—pancreatic cancer	1.12e-05	0.000301	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	1.11e-05	0.000298	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	1.11e-05	0.000297	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	1.1e-05	0.000295	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.08e-05	0.00029	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	1.08e-05	0.000289	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GCG—pancreatic cancer	1.08e-05	0.000288	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HIF1A—pancreatic cancer	1.08e-05	0.000288	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GCG—pancreatic cancer	1.07e-05	0.000287	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TSC2—pancreatic cancer	1.07e-05	0.000287	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.07e-05	0.000286	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GCG—pancreatic cancer	1.06e-05	0.000284	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—APOE—pancreatic cancer	1.05e-05	0.000281	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.05e-05	0.00028	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.04e-05	0.000279	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—TYMS—pancreatic cancer	1.04e-05	0.000278	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.03e-05	0.000277	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—KDR—pancreatic cancer	1.03e-05	0.000275	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	1.03e-05	0.000275	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	1.02e-05	0.000274	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	1.01e-05	0.000271	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—STK11—pancreatic cancer	1.01e-05	0.000271	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—STK11—pancreatic cancer	1.01e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—STK11—pancreatic cancer	9.99e-06	0.000267	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NFKBIA—pancreatic cancer	9.79e-06	0.000262	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NOTCH1—pancreatic cancer	9.69e-06	0.000259	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	9.51e-06	0.000255	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	9.48e-06	0.000254	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CG—pancreatic cancer	9.48e-06	0.000254	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—NRAS—pancreatic cancer	9.48e-06	0.000254	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	9.39e-06	0.000251	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EGF—pancreatic cancer	9.37e-06	0.000251	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.13e-06	0.000244	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.1e-06	0.000244	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.01e-06	0.000241	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	8.87e-06	0.000237	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	8.84e-06	0.000237	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	8.77e-06	0.000235	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	8.75e-06	0.000234	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	8.74e-06	0.000234	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	8.66e-06	0.000232	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HES1—pancreatic cancer	8.66e-06	0.000232	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—EGFR—pancreatic cancer	8.64e-06	0.000231	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HES1—pancreatic cancer	8.63e-06	0.000231	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HES1—pancreatic cancer	8.55e-06	0.000229	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOE—pancreatic cancer	8.44e-06	0.000226	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CD—pancreatic cancer	8.33e-06	0.000223	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	8.29e-06	0.000222	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	8.26e-06	0.000221	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.25e-06	0.000221	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	8.18e-06	0.000219	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—KRAS—pancreatic cancer	8.16e-06	0.000218	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	7.97e-06	0.000213	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	7.94e-06	0.000213	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	7.86e-06	0.00021	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CG—pancreatic cancer	7.62e-06	0.000204	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TERT—pancreatic cancer	7.59e-06	0.000203	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TERT—pancreatic cancer	7.56e-06	0.000202	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—PIK3CA—pancreatic cancer	7.49e-06	0.000201	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TERT—pancreatic cancer	7.49e-06	0.0002	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARG—pancreatic cancer	7.35e-06	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CB—pancreatic cancer	7.26e-06	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	7.25e-06	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	7.24e-06	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	7.23e-06	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	7.21e-06	0.000193	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	7.16e-06	0.000192	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	7.14e-06	0.000191	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOE—pancreatic cancer	7.08e-06	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOE—pancreatic cancer	7.06e-06	0.000189	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOE—pancreatic cancer	6.99e-06	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL8—pancreatic cancer	6.98e-06	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KDR—pancreatic cancer	6.94e-06	0.000186	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—HRAS—pancreatic cancer	6.93e-06	0.000186	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KDR—pancreatic cancer	6.92e-06	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KDR—pancreatic cancer	6.85e-06	0.000183	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AKT1—pancreatic cancer	6.74e-06	0.00018	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CD—pancreatic cancer	6.7e-06	0.000179	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CASP3—pancreatic cancer	6.68e-06	0.000179	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	6.6e-06	0.000177	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	6.58e-06	0.000176	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	6.54e-06	0.000175	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	6.51e-06	0.000174	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	6.51e-06	0.000174	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCND1—pancreatic cancer	6.5e-06	0.000174	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	6.45e-06	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CTNNB1—pancreatic cancer	6.44e-06	0.000172	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	6.39e-06	0.000171	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	6.39e-06	0.000171	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	6.37e-06	0.00017	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	6.37e-06	0.00017	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGF—pancreatic cancer	6.32e-06	0.000169	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MMP9—pancreatic cancer	6.31e-06	0.000169	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	6.31e-06	0.000169	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	6.31e-06	0.000169	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGF—pancreatic cancer	6.3e-06	0.000169	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PTEN—pancreatic cancer	6.28e-06	0.000168	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	6.24e-06	0.000167	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AKT1—pancreatic cancer	6.12e-06	0.000164	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CB—pancreatic cancer	5.84e-06	0.000156	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	5.82e-06	0.000156	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SRC—pancreatic cancer	5.82e-06	0.000156	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	5.8e-06	0.000155	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTGS2—pancreatic cancer	5.78e-06	0.000155	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	5.75e-06	0.000154	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—VEGFA—pancreatic cancer	5.67e-06	0.000152	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	5.62e-06	0.00015	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—STAT3—pancreatic cancer	5.61e-06	0.00015	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	5.6e-06	0.00015	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NRAS—pancreatic cancer	5.6e-06	0.00015	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.56e-06	0.000149	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.55e-06	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	5.55e-06	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	5.5e-06	0.000147	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.49e-06	0.000147	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	5.48e-06	0.000147	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	5.43e-06	0.000145	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MYC—pancreatic cancer	5.22e-06	0.00014	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TGFB1—pancreatic cancer	5.2e-06	0.000139	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EGFR—pancreatic cancer	5.1e-06	0.000137	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.05e-06	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTEN—pancreatic cancer	5.04e-06	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	5.04e-06	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	4.99e-06	0.000134	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	4.9e-06	0.000131	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	4.88e-06	0.000131	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	4.83e-06	0.000129	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—KRAS—pancreatic cancer	4.82e-06	0.000129	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	4.71e-06	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	4.69e-06	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	4.68e-06	0.000125	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	4.66e-06	0.000125	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	4.65e-06	0.000124	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	4.62e-06	0.000124	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	4.55e-06	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	4.53e-06	0.000121	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	4.5e-06	0.000121	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	4.49e-06	0.00012	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	4.49e-06	0.00012	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	4.45e-06	0.000119	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CA—pancreatic cancer	4.43e-06	0.000118	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	4.38e-06	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	4.37e-06	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	4.34e-06	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	4.33e-06	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	4.33e-06	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	4.29e-06	0.000115	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TP53—pancreatic cancer	4.28e-06	0.000115	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	4.26e-06	0.000114	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	4.24e-06	0.000114	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	4.23e-06	0.000113	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	4.22e-06	0.000113	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	4.2e-06	0.000112	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	4.18e-06	0.000112	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	4.13e-06	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	4.12e-06	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	4.1e-06	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	4.08e-06	0.000109	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	3.92e-06	0.000105	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	3.91e-06	0.000105	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	3.87e-06	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	3.82e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	3.81e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	3.78e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	3.78e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	3.77e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	3.77e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	3.76e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	3.74e-06	0.0001	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	3.73e-06	9.97e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	3.62e-06	9.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	3.56e-06	9.52e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	3.52e-06	9.41e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	3.51e-06	9.39e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	3.51e-06	9.38e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	3.5e-06	9.36e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	3.47e-06	9.29e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	3.46e-06	9.27e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	3.44e-06	9.21e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	3.43e-06	9.18e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	3.4e-06	9.09e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	3.25e-06	8.7e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	3.24e-06	8.67e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	3.21e-06	8.58e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.99e-06	7.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.98e-06	7.96e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.95e-06	7.89e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AKT1—pancreatic cancer	2.91e-06	7.78e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	2.89e-06	7.73e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	2.88e-06	7.7e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	2.85e-06	7.63e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	2.76e-06	7.39e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	2.75e-06	7.37e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2.73e-06	7.3e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	2.44e-06	6.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	2.43e-06	6.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	2.41e-06	6.44e-05	CbGpPWpGaD
